Concepedia

James R. Shoblock

JR

Statistics

Publications

18

Citations

1.3K

H-Index

16

Active since

2003

Affiliations

Johnson & Johnson (United States)(Current)

Janssen (United States)

Neurobehavioral Systems

Albany Medical Center Hospital

University of California, Los Angeles

James R. Shoblock is an author at Johnson & Johnson (United States) specializing in neuropharmacology, neuroscience, and pharmacology.

ORCID

Publications per year

2003–2019

18

Publications

18

Pharmacological characterization of a novel centrally permeable <scp>P2X7</scp> receptor antagonist: <scp>JNJ</scp>‐47965567

Anindya Bhattacharya, Qi Wang, Hong Ao et al. · British Journal of Pharmacology · 2013 · 198 citations · Full text

, , +17

Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats

James R. Shoblock, Eric B. Sullivan, Isabelle M. Maisonneuve et al. · Psychopharmacology · 2003 · 184 citations

, , +12

Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement

James R. Shoblock, Natalie Welty, Leah Aluisio et al. · Psychopharmacology · 2010 · 159 citations

, , +15

Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia

Pascal Bonaventure, Jonathan Shelton, Sujin Yun et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 82 citations

, , +14

Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice

Pamela D. Skoubis, Hoa A. Lam, James R. Shoblock et al. · European Journal of Neuroscience · 2005 · 82 citations

, , +16

1–5 of 18